---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-073163"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:43:48.421340+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics enters $1B accelerated share repurchase agreements with Citibank

## Summary
- Two ASR agreements with Citibank: $500M uncollared and $500M collared; total upfront payment $1B due Aug 4, 2025.
- Uncollared ASR: initial delivery ~1.27M shares (75% of expected); final settlement expected Q4 2025 based on VWAP less discount.
- Collared ASR: initial delivery ~850K shares (50% of expected); additional delivery after hedging; final settlement expected Q1 2026 with collar.
- At July 30, 2025, company had ~45.2M shares outstanding; CEO cites confidence in intrinsic value and cash flow generation.

## SEC filing metadata
- accession: 0001104659-25-073163
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465925073163/0001104659-25-073163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465925073163/tm2522276d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-073163
- JSON: https://secwatch.observer/filing/0001104659-25-073163.json
- Plain text: https://secwatch.observer/filing/0001104659-25-073163.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.